hmpl-013 and Cognitive-Dysfunction

hmpl-013 has been researched along with Cognitive-Dysfunction* in 1 studies

Other Studies

1 other study(ies) available for hmpl-013 and Cognitive-Dysfunction

ArticleYear
Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA).
    European journal of pharmacology, 2023, Jan-15, Volume: 939

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cerebral Amyloid Angiopathy; Cognitive Dysfunction; Endothelial Cells; Humans; Mice; Mice, Transgenic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2023